Ligand News and Research

RSS

Researchers track how key brain receptor works

For the first time, researchers in the lab of CSHL Professor Hiro Furukawa have been able to track each atom in the NMDA receptor, an important brain protein, as it transmits or inhibits neural signals.

1 Jul 2020

Chiral ligands can help develop novel drugs and bioactive compounds

Numerous therapeutic compounds—such as amino acids, enzymes, and proteins— that are currently available in the market are “chiral compounds.”

1 Jul 2020

New method to synthesize cancer-fighting phytochemicals

Phytoalexins have attracted a great deal of interest because of their major role in plant health and their health-promoting effects in humans.

26 Jun 2020

'Relaxed' T Cells are Critical To Immune Response

Your T cells manage what seems like an improbable task: quickly finding a few invaders among the many imposters in your body to trigger its immune response.

17 Jun 2020

Exploring the cradle of hematopoietic stem cells

Researchers from the group of Catherine Robin at the Hubrecht Institute characterized the molecular landscape of the aorta that supports the generation of the first Hematopoietic Stem Cells (HSCs) in the embryo.

5 Jun 2020

A New Mechanism Triggering Cell Death And Inflammation: A Left Turn That Kills

Z-form nucleic acids are double-stranded DNA and RNA molecules with a left-handed double helix structure, as opposed to the right-handed double helix.

2 Apr 2020

Bacteria’s ability to develop novel peptides for cancer treatment

At Texas A&M University, chemists have identified a new way to beat viruses at their own game—take a p[h]age from bacteria’s playbook and, in the process, develop new kinds of drugs to combat cancer and a range of other human diseases.

20 Mar 2020

A new study finds a potential immunotherapeutic pan-target on cancer cells

In a genome-wide CRISPR-Cas9 screen published in Nature Immunology in January 2020, a group of researchers described a potential universal target on cancer cells.

12 Feb 2020